1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: Over 60 Sponsor: Other Protocol IDs: SPON 845-10, 2010-021444-18, 10/MRE09/27, NCT01236144
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 2689-CL-2004, 2011-005408-13, NCT01565668
|
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 60 Sponsor: Pharmaceutical / Industry Protocol IDs: 2689-CL-0005, NCT01390337
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 21 Sponsor: Other Protocol IDs: T2009-004, NCT01411267
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 2689-CL-0011, NCT01468467
|